Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

由 Melariri, Paula, Kalombo, Lonji, Nkuna, Patric, Dube, Admire, Hayeshi, Rose, Ogutu, Benhards, Gibhard, Liezl, deKock, Carmen, Smith, Peter, Wiesner, Lubbe, Swai, Hulda
發表在 Int J Nanomedicine (2015)

Spray-Dried, Nanoencapsulated, Multi-Drug Anti-Tuberculosis Therapy Aimed at Once Weekly Administration for the Duration of Treatment

由 Kalombo, Lonji, Lemmer, Yolandy, Semete-Makokotlela, Boitumelo, Ramalapa, Bathabile, Nkuna, Patric, Booysen, Laetitia L.L.I.J., Naidoo, Saloshnee, Hayeshi, Rose, Verschoor, Jan A., Swai, Hulda S.
發表在 Nanomaterials (Basel) (2019)